Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory.
Roller Compaction Process Optimization Using At-Line Particle Characterization
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
METTLER TOLEDO recently announced that a free webinar, “Roller Compactions Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. In this webinar, the application of in situ particle characterization is demonstrated to map the design space and optimize a series of roller compaction runs while varying raw materials, flow rates, and roller compaction forces. (PRWeb Nov 20, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3229434.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 21, 2009 Category: Pharmaceuticals Source Type: news
Process Analytical Technology (PAT) in Green Chemistry and Green EngineeringEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
METTLER TOLEDO recently announced that Dr. Dominique Hebrault will present a free webinar, “The Role of Process Analytical Technology (PAT) in Green Chemistry and Green Engineering” on December 1, 2009. (PRWeb Nov 20, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3229224.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 21, 2009 Category: Pharmaceuticals Source Type: news
Dendreon Receives FDA Acknowledgement Of Complete ResponseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dendreon Corporation (Nasdaq: DNDN) announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. (Source: Pharma Industry News From Medical News Today)
Source: Pharma Industry News From Medical News Today - November 21, 2009 Category: Pharmaceuticals Tags: Prostate / Prostate Cancer Source Type: news
In Cancer Testing, Less Is BetterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Worries that widespread screening for breast and cervical cancers can lead to unnecessary harm prompted decisions by two medical organizations to recommend less preventive testing. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 21, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Democrats Get Key Vote on Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Nelson said he will vote to advance the Senate health-care bill in a crucial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 21, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
The Henry Ford of Heart SurgeryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In India, Devi Shetty's heart hospital offers cutting-edge medical care at a fraction of what it costs elsewhere in the world. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 21, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Swine Flu Seen as CrestingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The current wave of swine flu may have peaked in the U.S., but the illness remains widespread and the threat of another wave remains as officials in Norway reported a mutation of the virus. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 21, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Democrats Get Key Vote on Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Nelson said he will vote to advance the Senate health-care bill in a crucial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 21, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
In Cancer Testing, Less Is BetterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Worries that widespread screening for breast and cervical cancers can lead to unnecessary harm prompted decisions by two medical organizations to recommend less preventive testing. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 21, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
The Henry Ford of Heart SurgeryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In India, Devi Shetty's heart hospital offers cutting-edge medical care at a fraction of what it costs elsewhere in the world. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Cost Was Factor in Screening AdviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The issue of medical costs wasn't entirely absent from this week's decision by two medical organizations to recommend less intensive preventive testing for breast and cervical cancers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In AdultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder
NEW YORK--(HSMN NewsFeed)--Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon(R) (zipras... Biopharmaceuticals, FDAPfizer, Geodon, ziprasidone, bipolar disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Saatchi & Saatchi Wellness Names Russell as Managing DirectorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAATCHI & SAATCHI WELLNESS NAMES RUSSELL AS MANAGING
DIRECTOR
NEW YORK, NY, November 20, 2009-Saatchi & Saatchi Wellness
(SSW), a division of the Publicis Healthcare Communications Group,
announced today that Ned Russell has been named EVP,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Ingen Enters Hospital and Therapy Markets With Expected Revenue IncreaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YUCAIPA, Calif., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the company is now marketing direct to the hospital and therapy respiratory markets. Ingen's CEO, Scott Sand, will discuss these new markets this coming Tuesday, November 24, 2009 at 11:34AM eastern standard time on The Money Channel's American Scene Radio with host Steve Crowley. (Source: Medical...
Source: Medical News (via PRIMEZONE) - November 20, 2009 Category: Pharmaceuticals Source Type: news
Integra LifeSciences to Present at the Piper Jaffray Health Care and JP Morgan SMid Cap Conferences in DecemberEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLAINSBORO, N.J., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in December. (Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - November 20, 2009 Category: Pharmaceuticals Source Type: news
Genasense Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced MelanomaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Data Presented at International Melanoma Conference in
Berlin
Results Follow Decision by Company to Continue Phase 3
AGENDA Trial for Overall Survival
BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Nov 20, 2009 - Genta
Incorporated (OTCBB:... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 20, 2009 Category: Pharmaceuticals Source Type: clinical trials
Sen. Nelson to Vote to Advance Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Nelson said he will vote to advance the Senate health-care bill in a crucial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
J&J stays true to its diversified modelEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson defends its strategy, with its three broad divisions of medical devices, consumer health and pharmaceuticals, even as the approach fails to shield it from industry pains (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 20, 2009 Category: Pharmaceuticals Source Type: news
Ranbaxy recalls over 4,000 cartons of acne drug in USEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ranbaxy Laboratories has initiated a voluntary recall of 4,348 cartons of its best-selling drug Sotret (isotretinoin, 40 mg) used to treat acne in the US, as they are a part of one batch of tablets which were found to be ‘out of specification’. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Sen. Nelson to Vote to Advance Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Nelson said he will vote to advance the Senate health-care bill in an initial procedural vote, the first of three Democratic holdouts to back the measure. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
da Vinci Approved in JapanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUNNYVALE, Calif., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the industry leader in surgical robotics, today announced that it has received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) to allow marketing of its da Vinci S System in Japan. (Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - November 20, 2009 Category: Pharmaceuticals Source Type: news
European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Roche announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that have been filed for marketing authorisation in Europe, has issued a negative opinion relating to the approval of Avastin (bevacizumab) alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma (GBM), the most aggressive type of primary malignant brain cancer. (Source: Roche Investor Update)
Source: Roche Investor Update - November 20, 2009 Category: Pharmaceuticals Source Type: organizations
Banner Health Partners with CBORD to Develop an Enterprise-Wide Model for Sharing TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ITHACA, N.Y., Nov. 20, 2009 (GLOBE NEWSWIRE) -- The CBORD Group, Inc., the leading provider of food and nutrition management and cashless card systems to healthcare facilities, announced today that Banner Del E. Webb Medical Center, in Sun City West, AZ, is slated to go live this month with CBORD's Room Service solution. For Banner Health, this is the fifth facility to support the CBORD Room Service installation through its franchise model of sharing new technology. (Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - November 20, 2009 Category: Pharmaceuticals Source Type: news
Antitrust Lawyer Files Suit to Stop Pfizer MergerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
[The Day, New
London, Conn.]
From Day, The (New London, CT) (November 20, 2009)
Nov. 20--A prominent San Francisco antitrust attorney said
Thursday he has filed a request in federal court for a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
19.11.09: Positive Results from Chronic Study with Bayer's Rivaroxaban Will be Presented As a Late Breaker at ASH 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Positive Results from Chronic Study with Bayer's Rivaroxaban Will be Presented As a Late Breaker at ASH 2009Endpoints met in EINSTEIN-Extension Trial in the Secondary Prevention of Recurrent Symptomatic VTEmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - November 20, 2009 Category: Pharmaceuticals Source Type: news
DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management StrategiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC. (PRWeb Nov 19, 2009)
Read the full story at http://www.prweb.com/releases/DIA/Safety_Conference/prweb3230364.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 20, 2009 Category: Pharmaceuticals Source Type: news
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International DistributionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Nutra Pharma has introduced Nyloxin OTC, an over-the-counter pain reliever, that will be marketed and sold through international distribution channels alongside the Company's prescription pain reliever, Nyloxin Rx. (PRWeb Nov 19, 2009)
Read the full story at http://www.prweb.com/releases/Nutra_Pharma/Nyloxin_OTC/prweb3231994.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 20, 2009 Category: Pharmaceuticals Source Type: news
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal StentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets
NATICK, Mass. and LONDON, Nov. 20 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE: BSX ) today an... Devices, Interventional, Gastroenterology, FDABoston Scientific, WallFlex, Esophageal Stent, esophageal stricture (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial HypertensionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations
NEW YORK--(HSMN NewsFeed)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio(R) (sildenafil) Injection, an intravenous form... Biopharmaceuticals, FDAPfizer, Revatio, sildenafil, phosphodiesterase, pulmonary arterial hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
FDA Extends Review of NDA for ExalgoEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ST. LOUIS--(HSMN NewsFeed)--Covidien (NYSE:COV ), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has set a new action date under the Prescription Drug User Fee Act for the review of the Ne... Biopharmaceuticals, FDACovidien, Exalgo, hydromorphone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Smith and Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield InjuriesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
"Fracture putty" system to improve standard of care for injured soldiers
MEMPHIS, Tenn., Nov. 20 (HSMN NewsFeed) -- Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division is pleased to announce the signing of a technology development cont... Devices, OrthopaedicSmith & Nephew, fracture putty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
The Botax? Nip/Tuck Levy to Help Health Care PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 20, 2009)
WASHINGTON--They call it the "Botax." The White House and Senate
Democrats have turned to a proposal to tax breast implants, tummy
tucks, wrinkle-smoothing injections and other procedures as they
search for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Moody's Gives Negative View on Pharma CreditEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
NEW YORK--Moody's Investors Service issued a negative opinion on
the pharmaceutical industry Thursday, saying drugmaker credit
ratings will be under pressure until early 2012 because they won't
be able to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Retiring Lilly Research Exec Steven Paul Gets $2 Million in Severance [The Indianapolis Star]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Indianapolis Star (IN) (November 20, 2009)
Nov. 20--The top research executive at Eli Lilly and Co. will
receive a $2 million cash severance payment and be credited with
extra years of service when he retires in February -- a move... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Roche announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that have been filed for marketing authorisation in Europe, has issued a negative opinion relating to the approval of Avastin (bevacizumab) alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive glioblastoma (GBM), the most aggressive type of primary malignant brain cancer. (Source: Roche Media News)
Source: Roche Media News - November 20, 2009 Category: Pharmaceuticals Source Type: organizations
GLG Life Tech Corporation: GLG Life Tech Corporation Commences Trading on NASDAQEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) GLG Life Tech Corporation (TSX: GLG)(NASDAQ: GLGL) ("GLG" or the "Company"), the vertically integrated leader in the agricultural and industrial development of high quality stevia extracts, announced today that it has commenced trading on the NASDAQ Global Market under the symbol "GLGL". GLG's common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech GLG GLGL Source Type: news
ProMetic Life Sciences Inc.: SaBTO Recommends Use of P-Capt(R) Prion Reduction Filter to Protect Children From vCJD Blood TransmissionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL, QUEBEC, CANADA and LILLE, FRANCE (MARKET WIRE) ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") and MacoPharma SA ("MacoPharma") announce that the Advisory Committee on the Safety of Blood, Tissues and Organs ("SaBTO"), an independent Committee that advises the UK Department of Health ("DoH"), has recommended the adoption of the P-Capt(R) prion reduction filter to pre-treat red blood cells destined for children born since 1 January 1996. The filter, which 'cleans' blood prior to use, removes the prion responsible for variant Creutzfeldt-Jakob disease ("vCJD"). The Committee also indicated that the requirement ...
Source: Market Wire - Pharmaceuticals and Biotech - November 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech PLI Source Type: news
Experienced Biotech and Regulatory Expert Becomes Formal Member of the biOasis TeamEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, British Columbia, Nov. 20, 2009 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) is pleased to announce that Dr. Delara Karkan has been named as Senior Industry Scientific Advisor. (Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - November 20, 2009 Category: Pharmaceuticals Source Type: news
Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO--(BUSINESS WIRE)--Nov 20, 2009 - Ligand
Pharmaceuticals Incorporated (NASDAQ: LGND) today announced
that data from a preclinical study on its selective androgen
receptor modulator (SARM) LGD-4033 was featured in a poster
presentation at... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 20, 2009 Category: Pharmaceuticals Source Type: clinical trials
Lawmakers Call For Inquiry Into Pharmaceutical Company Price HikesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Reuters: "Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system. (Source: Pharma Industry News From Medical News Today)
Source: Pharma Industry News From Medical News Today - November 20, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
Daschle Still Making Voice Heard On Health CareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Hill reports that former Senate Majority Leader Tom Daschle helped Obama Administration officials strategize to win health care reform votes from Senators on Capitol Hill Wednesday. (Source: Pharma Industry News From Medical News Today)
Source: Pharma Industry News From Medical News Today - November 20, 2009 Category: Pharmaceuticals Tags: Health Insurance / Medical Insurance Source Type: news
Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical StudiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Inovio's SynConTM Universal Flu
Vaccines Provide 100% Protection in Ferrets against Death and
Sickness in a Challenge Study with the Pandemic H1N1 Virus
SAN DIEGO--(BUSINESS WIRE)--Nov 20, 2009 - Inovio Biomedical
Corporation (NYSE Amex:INO), a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 20, 2009 Category: Pharmaceuticals Source Type: clinical trials
Adamas Pharmaceuticals Expands Clinical Study For Triple-Combination Antiviral Drug Therapy In Immune Compromised PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Adamas Pharmaceuticals, Inc., a privately held company, announced that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. (Source: Pharma Industry News From Medical News Today)
Source: Pharma Industry News From Medical News Today - November 20, 2009 Category: Pharmaceuticals Tags: Swine Flu Source Type: news
ACTEMRA Improves Signs and Symptoms in Children with Systemic Onset Juvenile Idiopathic Arthritis (sJIA)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Roche announced today that ACTEMRA (tocilizumab, known as RoACTEMRA within the EU) successfully met its primary endpoint in a paediatric study of systemic onset Juvenile Idiopathic Arthritis (sJIA), by significantly improving disease signs and symptoms, a critical effectiveness measure of a sJIA treatment. (Source: Roche Investor Update)
Source: Roche Investor Update - November 20, 2009 Category: Pharmaceuticals Source Type: organizations
Democrats Pitch Health Bill to VotersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Senate Democrats touted the immediate benefits their health bill would bring to Americans, aware that the cost and reach of the bill may already be turning off some voters ahead of the 2010 elections. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Group Clarifies Mammography AdviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The task force that loosened breast-cancer screening guidelines this week clarified its position, in response to the intense backlash its new recommendations have prompted. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Tax on Rich, Levies Stir Health DebateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Senate health bill does without a new surtax on the wealthy that House Democrats' legislation includes, but Senate Democrats have their own taxes that are stirring controversy. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
